LHX CEO exercises 14,171 options at $162.30; updates holdings
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
L3Harris Technologies (LHX) Chair and CEO Christopher E. Kubasik reported insider transactions. On 11/13/2025, he exercised 14,171 non‑qualified stock options at $162.30 per share (code M) and sold 14,171 shares at $301.05 (code S) pursuant to a Rule 10b5‑1(c) plan adopted on June 13, 2025.
Following these transactions, he directly owned 144,426 shares and held 30,000 shares indirectly via a grantor retained annuity trust. A separate transaction (code I) disposed of 1,156.37 shares held through the issuer’s retirement plan at $288.37, leaving 0 shares via the plan. The footnote notes plan-based adjustments of 1,151.82 shares excluded and 4.56 shares acquired as of 11/13/2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 14,171 shares ($4,266,180)
Net Sell
5 txns
Insider
KUBASIK CHRISTOPHER E
Role
Chair and CEO
Sold
14,171 shs ($4.27M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (Right to Buy) | 14,171 | $0.00 | -- |
| Exercise | Common Stock, Par Value $1.00 | 14,171 | $162.30 | $2.30M |
| Sale | Common Stock, Par Value $1.00 | 14,171 | $301.05 | $4.27M |
| I | Common Stock, Par Value $1.00 | 1,156.37 | $288.37 | $333K |
| holding | Common Stock, Par Value $1.00 | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock, Par Value $1.00 — 158,597 shares (Direct);
Common Stock, Par Value $1.00 — 0 shares (Indirect, By retirement plan)
Footnotes (1)
- Excludes 1,151.82 shares held by the Issuer's retirement plan (the "Plan) previously reported as directly owned, and 4.56 shares acquired through the Plan based on information provided by the Plan's administrators as of 11/13/2025. Pursuant to written plan intended to satisfy Rule 10b5-1(c), adopted by the reporting person on June 13, 2025.
FAQ
What insider transaction did LHX report?
The CEO exercised 14,171 stock options at $162.30 (code M) and sold 14,171 shares at $301.05 (code S) on 11/13/2025.
Was the LHX CEO’s sale under a 10b5-1 plan?
Yes. The sale was pursuant to a written plan intended to satisfy Rule 10b5‑1(c), adopted on June 13, 2025.
What do the Form 4 footnotes disclose for LHX?
They state 1,151.82 plan shares were excluded from direct ownership and 4.56 shares were acquired through the plan as of 11/13/2025.
What type of derivative security was exercised?
A non‑qualified stock option (right to buy) for 14,171 shares with a $162.30 exercise price.